KhanA, KhanSR, LeventhalRM, BrownWA. Symptom reduction and suicide risk among patients treated with placebo in antipsychotic clinical trials: an analysis of the Food and Drug Administration database. Am J Psychiatry158:1449–1454, 2001.
2.
HorrobinDF. The philosophical basis of peer review and the suppression of innovation. J Am Med Assoc263:1438–1441, 1990.
3.
WurtmanRJ, BettikerRL. The slowing of treatment discovery, 1965–1995. Nat Med1:1122–1125, 1995.
4.
OldhamJM. Heinz E. Lehmann, MD (1911–2000): Obituary. Arch Gen Psychiatry58:1178, 2001.
5.
HorrobinDF. Realism in drug discovery: could Cassandra be right?Nat Biotechnol19:1099–1100, 2001.
6.
HorrobinDF. Innovation in the pharmaceutical industry. J R Soc Med93:341–345, 2000.
7.
RosenbergL.Physician-scientists: endangered and essential. Science283:331–332, 1999.
